Literature DB >> 11389004

Wound-healing defects in mice lacking fibrinogen.

A F Drew1, H Liu, J M Davidson, C C Daugherty, J L Degen.   

Abstract

In addition to its key role in the control of blood loss following injury, fibrin(ogen) has been proposed to play an important role in tissue repair by providing an initial matrix that can stabilize wound fields and support local cell proliferation and migration. To test directly these concepts, the effect of fibrinogen deficiency on cutaneous tissue repair in mice was investigated using incisional and excisional wounds. The time required to overtly heal wounds was similar in fibrinogen-deficient and control mice, but histologic evaluation revealed distinct differences in the repair process, including an altered pattern of epithelial cell migration and increased epithelial hyperplasia. Furthermore, granulation tissue in fibrinogen-deficient mice failed to adequately close the wound gap, resulting in persistent open wounds or partially covered sinus tracts. The tensile strength of these wounds was also reduced compared with control mice. The most profound defect in wound tissue organization was observed in fibrinogen-deficient mice following the subcutaneous implantation of a porous tubing chamber. Cells migrated into the wall of the implants at a similar rate as control mice, but cells from fibrinogen-deficient animals were unable to efficiently organize and migrate into wound fluid-filled dead space within the center of the implants. These studies show that re-epithelialization, granulation tissue formation, including the establishment of neovasculature, and the formation of fibrotic scar tissue can proceed in the absence of fibrin(ogen) and all of its proteolytic derivatives. However, fibrin (ogen) is important for appropriate cellular migration and organization within wound fields and in initially establishing wound strength and stability. (Blood. 2001;97:3691-3698)

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11389004     DOI: 10.1182/blood.v97.12.3691

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  58 in total

1.  Colitis-associated cancer is dependent on the interplay between the hemostatic and inflammatory systems and supported by integrin alpha(M)beta(2) engagement of fibrinogen.

Authors:  Kris A Steinbrecher; Netanel A Horowitz; Elizabeth A Blevins; Kelley A Barney; Maureen A Shaw; Eleana Harmel-Laws; Fred D Finkelman; Matthew J Flick; Malinda D Pinkerton; Kathryn E Talmage; Keith W Kombrinck; David P Witte; Joseph S Palumbo
Journal:  Cancer Res       Date:  2010-03-16       Impact factor: 12.701

Review 2.  Wound healing in hemophilia B mice and low tissue factor mice.

Authors:  Dougald M Monroe; Nigel Mackman; Maureane Hoffman
Journal:  Thromb Res       Date:  2010-02-19       Impact factor: 3.944

3.  Enhanced mesenchymal stromal cell recruitment via natural killer cells by incorporation of inflammatory signals in biomaterials.

Authors:  Catarina R Almeida; Daniela P Vasconcelos; Raquel M Gonçalves; Mário A Barbosa
Journal:  J R Soc Interface       Date:  2011-07-13       Impact factor: 4.118

4.  Roles for thrombin and fibrin(ogen) in cytokine/chemokine production and macrophage adhesion in vivo.

Authors:  Frank M Szaba; Stephen T Smiley
Journal:  Blood       Date:  2002-02-01       Impact factor: 22.113

5.  Evidence that integrin alpha IIb beta 3-dependent interaction of mast cells with fibrinogen exacerbates chronic inflammation.

Authors:  Toshihiko Oki; Koji Eto; Kumi Izawa; Yoshinori Yamanishi; Naoki Inagaki; Jon Frampton; Toshio Kitamura; Jiro Kitaura
Journal:  J Biol Chem       Date:  2009-09-15       Impact factor: 5.157

6.  Fibrinogen regulates the cytotoxicity of mycobacterial trehalose dimycolate but is not required for cell recruitment, cytokine response, or control of mycobacterial infection.

Authors:  Kaori Sakamoto; Rachel E Geisel; Mi-Jeong Kim; Bryce T Wyatt; Llewelyn B Sellers; Stephen T Smiley; Andrea M Cooper; David G Russell; Elizabeth R Rhoades
Journal:  Infect Immun       Date:  2009-12-22       Impact factor: 3.441

7.  Impaired factor XIII activation in patients with congenital afibrinogenemia.

Authors:  Françoise Bridey; Claude Négrier; Cedric Duval; Robert Ariëns; Philippe de Moerloose; Alessandro Casini
Journal:  Haematologica       Date:  2018-09-27       Impact factor: 9.941

8.  Bio-Adaption between Magnesium Alloy Stent and the Blood Vessel: A Review.

Authors:  Jun Ma; Nan Zhao; Lexxus Betts; Donghui Zhu
Journal:  J Mater Sci Technol       Date:  2015-12-24       Impact factor: 8.067

9.  Fibrin(ogen) drives repair after acetaminophen-induced liver injury via leukocyte αMβ2 integrin-dependent upregulation of Mmp12.

Authors:  Anna K Kopec; Nikita Joshi; Holly Cline-Fedewa; Anna V Wojcicki; Jessica L Ray; Bradley P Sullivan; John E Froehlich; Brendan F Johnson; Matthew J Flick; James P Luyendyk
Journal:  J Hepatol       Date:  2016-12-10       Impact factor: 25.083

10.  SufA - a bacterial enzyme that cleaves fibrinogen and blocks fibrin network formation.

Authors:  Christofer Karlsson; Matthias Mörgelin; Mattias Collin; Rolf Lood; Marie-Louise Andersson; Artur Schmidtchen; Lars Björck; Inga-Maria Frick
Journal:  Microbiology (Reading)       Date:  2009-01       Impact factor: 2.777

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.